|
|
Customized hybrid bioscaffolds for bone regeneration
Šťastný, Přemysl ; Šupová,, Monika (referee) ; Pabst, Willi (referee) ; Trunec, Martin (advisor)
Doktorská práce s názvem Individualizované hybridní podpůrné struktury pro regeneraci kostní tkáně je rozdělena do dvou částí. První část si klade za cíl ukázat vzájemný vztah mezi implantovaným materiálem a kostní tkání a současný stav poznání v oblasti vývoje matriálů na bázi fosforečnanů vápenatých a z nich vyráběných implantátů pro regeneraci kostní tkáně. Koncept individualizace a pečlivého výběru fázového složení implantátu představuje stěžejní body druhé části práce. Individualizace v této práci není chápána jako pouhé dosažení tvarové a rozměrové přesnosti implantátu. Velká pozornost byla věnována mikrostrukturním detailům, fázovému složení a distribuci jednotlivých fází, což umožňuje připravit specifický materiál na základě zamýšlené aplikace. Biologická odezva na připravené materiály byla vyhodnocena pomocí in-vitro a in-vivo testů. Doktorská práce ukazuje jak pochopení základních chemických a fyzikálních vlastností materiálu může pomoc při návrhu implantátu s vynikající biologickou odezvou. In-vivo aplikace navrženého materiálu a jeho srovnání s autograftním kostním štěpem, současným zlatým standardem, je jedinečným a cenným výstupem předložené práce.
|
|
|
Multipotent mesenchymal stromal cells in orthopedic: Potentiation of bone healing
Stehlík, David ; Trč, Tomáš (advisor) ; Janíček, Pavel (referee) ; Sedmera, David (referee)
The aim of the thesis was development of an innovative treatment of bone defects. Human multipotent mesenchymal stromal cells (MSC) play a crucial role in bone healing. Clinical applications of MSC require large amount of cells, which could be obtained by autologous expansion of MSC harvested from bone marrow. As a first step, the standard protocol of MSC expansion based on αMEM medium and fetal bovine serum (FBS) was used. Experiments replacing FBS by pooled human serum (HS) in the culture medium concluded in patenting of a new MSC cultivation protocol (EU 1999250, CR 301141). This one-step cultivation protocol and xenogeneic protein-free cultivation medium is based on CellGro® for Hematopoietic Cells' Medium, HS, human recombinant growth factors, dexamethasone, insulin and ascorbic acid. The preclinical in vitro and in vivo experiments with MSC from both expansion protocols were carried out. Fibrillar polylactic scaffolds were seeded with MSC, cultured, differentiated and implanted in immunodeficient mice (NOD/LtSz-Rag1-). Bone-like mineralized tissue containing vessels was observed. The MSC cultured according to patented method were classified as Advanced-therapy Medicinal Product and has to fulfil the European Medicines Agency regulations to enter the clinical trials. Nevertheless the use of MSC seems...
|
|
|
Skull Trepanation in Prehistory of the Europe: The Oldest Surgical Procedures
Moravec, Tomáš ; Komárek, Stanislav (advisor) ; Pankowská, Anna (referee)
The main aim of the thesis is to provide a comprehensive overview of trepanations in the prehistory of Europe and to compile a brief overview of the oldest findings in Europe and closer in the Czech Republic. At first, the thesis deals with the types of trepanations according to their execution and the problems with trepanation diagnosis, where the work focuses on various groups of defects created by different mechanisms, which can be incorrectly diagnosed as trepanations. Further, the thesis deals with the reasons for trepanation and the description of the trepanations tools and techniques used in the prehistory. It also briefly mentions the first references to surgical interventions and the origin of anesthesia. Additionally, the thesis deals with the overview of the oldest findings in Europe and the Czech Republic and their brief description. And finally, there is a mention of trepanations at the present time.
|
|
|
Skull trepanation in archaic ethnics
Moravec, Tomáš ; Komárek, Stanislav (advisor) ; Hroníková, Linda (referee)
This thesis is focused on skull trepanation in archaic ethnics. Trepanation has been used since the Stone Age almost all around the world and since that time have occured the constantly improved tools, trepanation techniques and used anesthesia. However to the present time we are not sure, what exactly was the motivation of then primitive nations to perform such a dangerous procedure. Trepanation has been the subject of many researches since the 19th century, which has been tasked with bringing closer knowledge about the procedure and what was the reason for doing it. This work should provide general knowledge about the topic of trepanations.
|
|
|
Multipotent mesenchymal stromal cells in orthopedic: Potentiation of bone healing
Stehlík, David ; Trč, Tomáš (advisor) ; Janíček, Pavel (referee) ; Sedmera, David (referee)
The aim of the thesis was development of an innovative treatment of bone defects. Human multipotent mesenchymal stromal cells (MSC) play a crucial role in bone healing. Clinical applications of MSC require large amount of cells, which could be obtained by autologous expansion of MSC harvested from bone marrow. As a first step, the standard protocol of MSC expansion based on αMEM medium and fetal bovine serum (FBS) was used. Experiments replacing FBS by pooled human serum (HS) in the culture medium concluded in patenting of a new MSC cultivation protocol (EU 1999250, CR 301141). This one-step cultivation protocol and xenogeneic protein-free cultivation medium is based on CellGro® for Hematopoietic Cells' Medium, HS, human recombinant growth factors, dexamethasone, insulin and ascorbic acid. The preclinical in vitro and in vivo experiments with MSC from both expansion protocols were carried out. Fibrillar polylactic scaffolds were seeded with MSC, cultured, differentiated and implanted in immunodeficient mice (NOD/LtSz-Rag1-). Bone-like mineralized tissue containing vessels was observed. The MSC cultured according to patented method were classified as Advanced-therapy Medicinal Product and has to fulfil the European Medicines Agency regulations to enter the clinical trials. Nevertheless the use of MSC seems...
|
guest ::
